CD8A and neoplasm: cDC1s specialize in intracellular antigen processing and presentation and in shaping antitumor immune responses by cross-presenting tumor-associated antigens to CD8+ T lymphocytes, which recognizes them via major histocompatibility complex class I (MHC I) signaling [13].